Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/254.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Bordetella (e.g., bordetella bronchiseptica, etc.) > Bordetella pertussis
Description: Subject matter wherein the bacterium is of the species Bordetella pertussis.


Patents under this class:
1 2

Patent Number Title Of Patent Date Issued
7485304 Non-toxic mucosal adjuvant Feb. 3, 2009
7465443 Acellular antibordetella vaccine Dec. 16, 2008
7427404 Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines Sep. 23, 2008
7393535 Adjuvants for use in vaccines Jul. 1, 2008
7285289 Nanoparticle vaccines Oct. 23, 2007
7279169 Mucosal DTPa vaccines Oct. 9, 2007
7211263 Use of adenylate cyclase or bacteria producing it as vaccines against Bordetella May. 1, 2007
RE39494 Inactivated mycoplasma hyopneumoniae and uses therefor Feb. 27, 2007
7105161 Proteinaceous adjuvants Sep. 12, 2006
7105317 Immunogenic compositions comprising vrg-gene products from Bordetella extracts Sep. 12, 2006
7087236 Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof Aug. 8, 2006
7070781 Nontoxic mucosal adjuvant Jul. 4, 2006
7070779 POLYPEPTIDES CONTAINING POLYMORPHISMS OF THE REPEATED REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS, AND BORDETELLA BRONCHISEPTICA, THEIR USE IN DIAGNOSTICS, AND IN IM Jul. 4, 2006
7056521 Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants Jun. 6, 2006
6929794 IL-12 as an adjuvant for Bordetella pertussis vaccines Aug. 16, 2005
6890530 Composition comprising fungi of genus trichoderma used as biological control agent and the applications thereof May. 10, 2005
6887484 Vaccine composition containing a promoter peptide May. 3, 2005
6814971 Adjuvants for use in vaccines Nov. 9, 2004
6733754 Adjuvants for use in vaccines May. 11, 2004
6713072 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine Mar. 30, 2004
6696065 Acellular pertussis vaccines and methods of preparation thereof Feb. 24, 2004
6660261 Bordetella strain expressing the FHA hybrid, liposomes and vaccines Dec. 9, 2003
6572861 Adjuvants for use in vaccines Jun. 3, 2003
6562352 Vaccine compositions for mucosal delivery May. 13, 2003
6517844 Compositions and method for immunizing polutry Feb. 11, 2003
6485946 Production of chitosan and chitin Nov. 26, 2002
6399076 Acellular pertussis vaccines and methods of preparation thereof Jun. 4, 2002
6387377 Acellular antibordetella vaccine May. 14, 2002
6368589 Use of autologous promoters to express gene products in Bordetella Apr. 9, 2002
6309648 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections Oct. 30, 2001
6284256 Bordetella bronchiseptica vaccine Sep. 4, 2001
6251606 Gene sequence and method for distinguishing cordyceps sinensis Jun. 26, 2001
6214356 Use of adenylate cyclase or bacteria producing it as vaccines against bordetella Apr. 10, 2001
6210685 Antigenic preparations and isolation of such preparations Apr. 3, 2001
6162433 Non antibiotic selectable markers for live vaccines Dec. 19, 2000
6127151 Antigenic preparations and the isolation of such preparations Oct. 3, 2000
6060067 Process for the preparation of tetanus toxoid vaccine May. 9, 2000
6046224 12 (S)--hete receptor blockers Apr. 4, 2000
6030625 Bordetella pertussis and Bordetella parapertussis strains Feb. 29, 2000
6019979 Anti-viral treatment with pertussis toxin B oligomer Feb. 1, 2000
6018022 Modification of pertussis toxin Jan. 25, 2000
5989564 Pertussis toxoid made by reacting pertussis toxin with the nitrating agent TNM Nov. 23, 1999
5985286 Bordetella strains Nov. 16, 1999
5980907 Vaccines containing bacteria attenuated by mutation of the htrA gene Nov. 9, 1999
5977304 Modification of pertussis toxin Nov. 2, 1999
5976544 Polypeptides and vaccines for Bordetellapertussis and method of use Nov. 2, 1999
5965385 Modification of pertussis toxin Oct. 12, 1999
5935580 Recombinant mutants for inducing specific immune responses Aug. 10, 1999
5925546 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine Jul. 20, 1999
5889172 DNA sequences for immunologically active peptides of pertussis toxin Mar. 30, 1999

1 2


 
 
  Recently Added Patents
Asphalt fiber panels for pavement construction and repair
Interlocking intramedullary nails with outer screw
Adaptive power state management
Elevator with vertical vibration compensation
Linearly polarized antenna and radar apparatus using the same
Digital broadcasting receiver
Semiconductor integrated circuit supplying voltage to a load using a charge pump and electronic device including the same
  Randomly Featured Patents
Intraluminal guidewire with hydraulically collapsible self-expanding protection device
Spiral ripple circumferential flow heat exchanger
Spray paint gun air stabilizing structure
Headset
Method of making miniature plug-in fuses of different fuse ratings
Automated induction toilet bowl seat lift system
Semiconductor memory with a clock synchronization device having a temperature controlled delay circuit
Vacuum assembly for recovering and dispensing flowable packaging materials
Image generating system and program
Hydroformylation catalyst and process of using it